REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Innovasalud Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Machinery, Equipment, and Supplies Merchant Wholesalers
Full name: Innovasalud Sas Profile Updated: February 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Innovasalud Sas is an enterprise based in Colombia. Its main office is in Cali. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on October 21, 2009. There are currently 12 (2024) people employed by Innovasalud Sas. The latest financial highlights indicate a net sales revenue increase of 31.1% in 2023. Its total assets grew by 16.91% over the same period. The net profit margin of Innovasalud Sas decreased by 4.95% in 2023.

Headquarters
Kr 37 # 5 B2 - 31
Cali; Valle del Cauca;

Contact Details: Purchase the Innovasalud Sas report to view the information.

Basic Information
Total Employees:
Purchase the Innovasalud Sas report to view the information.
Outstanding Shares:
Purchase the Innovasalud Sas report to view the information.
Incorporation Date:
October 21, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Innovasalud Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
31.1%▲
Total operating revenue
27.8%▲
Operating profit (EBIT)
-15.52%▼
Net Profit (Loss) for the Period
-22.24%▼
Total assets
16.91%▲
Total equity
11.49%▲
Operating Profit Margin (ROS)
-6.71%▼
Net Profit Margin
-4.95%▼
Return on Equity (ROE)
-4.47%▼
Quick Ratio
0.52%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo